Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Shock. 2016 Jul;46(1):75–82. doi: 10.1097/SHK.0000000000000571

Figure 1. hASC therapy improves survival following intestinal ischemia.

Figure 1

The use of hASCs increased seven day survival to 80% compared to a 40% seven day survival in vehicle control following intestinal ischemia. No survival benefit was seen with the use of keratinocytes (differentiated cell control). I/R = ischemia and reperfusion; hASC = Human adipose-derived stromal cell